INTRODUCTION
Vasomotor symptoms like hot flushes and sweating, local vaginal discomfort and urinary discomfort are classically associated with menopause (1, 2) . The use of estrogen combined with progestagens, hormone therapy (HT), has increased rapidly during the past twenty years. Only 7% of postmenopausal women from our area used HT in the early nineteeneighties (1) compared to almost 50 % around 1998 (3) . This increased use of HT in our area was similar as described in other countries (4, 5) . The increase was probably caused by women's and physician's knowledge and beliefs of beneficial effects from HT, e.g. on vasomotor symptoms (6) , osteoporosis and risk for fractures, colon cancer and Alzheimer's disease (7) , but may also have been affected by promotional activities from pharmaceutical companies (8) . Evidently, side effects from HT did not attract the same attention, like the increased risk of thromboembolic disease and breast cancer.
Epidemiological data collected over more than a decade have indicated that HT prevents cardiovascular disease (9, 10) , but this has been suggested to be at least partly explained by selection bias. Women using HT may for example be more aware of other health factors than nonusers (9) . Prospective, placebo-controlled studies have been unable to confirm these cardiovascular advantages in primary and secondary preventive studies like the WHI study (11) and the HERS study (12) , which even reported an increased risk of cardiovascular events during the first year after initiation of HT. The preventive effects on Alzheimer's disease and impaired cognition have also been disproved in the older age group used in the WHI study (13) . With these conflicting, and sometimes contradictory findings on risks and benefits from use of HT, it may be difficult for women to decide whether or not to use HT.
It is important that health care providers understand women's attitudes and expectations regarding menopause, in order to give optimal information and support to the individual woman. Recent publications about greater risks with HT than previously believed (11) (12) (13) (14) , make the situation more complicated and confusing for the help-seeking woman, and make it important that health care providers understand and are aware of women's beliefs and attitudes on menopause and HT.
It has been reported that women's conception of the menopause vary in relation to menopausal status and depending on the symptoms associated with her own menopausal transition (15) (16) (17) . A Swedish study (18) found that it was a discrepancy between women's actual beliefs and attitudes and what their doctors believe about their patient's beliefs and attitudes about menopause and HT.
It has previously been demonstrated that women's attitudes towards menopause and their knowledge of benefits and risks of HT have a direct effect on their use of HT (19) . In a Scottish survey from 1991, repeated 2000 (20) , attitudes towards the menopausal transition remained relatively stable between 1991 and 2000. Only the statements saying that menopause should be viewed as a medical condition and that women feel less feminine after menopause had changed.
After publication of results from the WHI, HERS and Million Women Study a number of studies from various countries have been performed finding a dramatic decrease in the use of HT (4, (21) (22) (23) (24) (25) . This decrease also appeared to coincide with changes in women's and doctor's attitudes to HT (24) (25) (26) (27) . There are few studies, however, regarding changes in attitudes towards the menopause transition, which might also have been affected by the media reports and should be clarified.
The objective of this study was to assess different attitudes and beliefs about the menopausal transition and HT and if these attitudes were different before and after 6 publication of the results from the WHI study and the HERS study. We also wanted to assess if these attitudes differed between peri-and postmenopausal women, and between users and nonusers of HT. (Table 1) . After each statement they were asked to tick a box in a five-graded Likertscale ranging from "agree totally" to "disagree totally". Other parts from this questionnaire have been analysed and published separately (25) . The questionnaire was validated in several steps. Three women between 49 and 56 years of age, having appointments at the outpatient clinic of gynecology at the University Hospital completed the first version of the questionnaire and were interviewed afterwards. After having modified some of the questions in order to clarify them, the new version of the questionnaire was sent to ten women, 50 to 59 years of age. Test-re-test stability was tested by letting the same ten women answer the questionnaire again two weeks later, without information beforehand that the questionnaire was to be answered twice. Seven of the ten women completed the questionnaire the second time. We analyzed the test-retest stability for the 11 questions on attitudes on menopause answered twice by the seven women (totally 77 duplicate questions). It appeared that 53 of the categorized responses were identical, 18 differed one The questionnaires were coded, which enabled us to send a reminder to those women who had not answered after four weeks. After the codes had been eliminated from the questionnaires, data were optically scanned into the computer and analyzed using SPSS for Windows (release 10.1.0). Optical scanning was checked manually and not until the first ten questionnaires had shown total agreement between optical and manual reading, the procedure was accepted.
METHODS
After analyzing the questions concerning the menopausal status and the use of HT, the women were divided into three groups: perimenopausal (i.e. last spontaneous menstrual bleeding within 6 months, no matter if the bleedings were irregular or not), postmenopausal using HT and postmenopausal without HT use. We considered women with 6 months without menstrual bleedings as postmenopausal, which is not according to the WHO definition, but Kaufert et al showed that menstrual bleedings occur in less than 10% of women after six months of amenorrhea (28) . These groups were then cross- Statistics: Pearson chi-square test was used when analyzing differences between groups.
The p-value was set to <0.05 (two-tailed) to be considered significant.
Ethics: The local ethics committee at the Faculty of Health Sciences, Linköping
University, approved the study design, including the questionnaire. In both cohorts about 10% of the women had undergone hysterectomy and approximately 3% were oophorectomized. About one third of the women had 9 years of education, one third between 10 and 12 years and one third more than 12 years of education. HT use did not differ between these three groups.
RESULTS

Of
Differences in attitudes to the menopausal transition between 1999 and 2003
The results of the questions on attitudes and beliefs about the menopausal transition are summarized in Table 2 Table 3 . Most HT users (91.9 %) agreed to at least some extent on the statement that differences between users and non-users of HT were the same in the two cohorts but the percentages in some cases were slightly different. Almost all women using HT thought that menopause is characterized by a hormonal deficiency, whereas slightly, but significantly, fewer nonusers supported this statement (p<0.001). The HT-users and non-users had similar attitudes as measured in all other questions.
DISCUSSION
This population based questionnaire study performed before and after publication of the HERS, WHI and Million Women studies showed that the attitudes towards the menopausal transition remained relatively stable despite of the major media reports on risks and benefits of HT and a dramatic change in HT use. On the other hand, HT use deceased rapidly probably not only caused by the media reports but also due to the societal context including the popular press, regulatory authorities and health advocates (8) . This is in agreement with the fact that attitudes, especially strong attitudes, are usually difficult to change (29) . A majority of the women in both cohorts regarded menopause as a natural process characterized by both hormonal deficiency and aging. The women in 2003, however, were slightly more determined regarding these statements compared with the cohort from 1999. The fact that women in 2003 had a clearer standpoint than in 1999 could maybe be caused by an increased awareness over time of the climacteric and HT in the society. On the other hand there were more obvious and significant differences between the both cohorts regarding actual use of HT and regarding attitudes towards use of HT, especially the statement that all women should use HT. This is probably a result of the media reports on risks and benefits of HT use (11) (12) 14) . Similar changes over time regarding attitudes towards HT are well documented since the first result from the Women's Health Initiative (WHI) and HERS studies were published (30) , whereas it has not, to our knowledge, previously been studied whether the attitudes towards the menopause transition differed before and after publication of these studies. The change in attitudes towards HT seems to correlate well with both prescription and use of HT in our area (25) . Women's perception that menopause is caused by hormonal deficiency, which was more evident in 2003 than in 1999, seems to affect actual HT use less than other factors, like their knowledge and perception of risks and benefits.
A high response rate is important for a good questionnaire study. Our response rate of over 70% in both questionnaires, of which we analyzed 70% after omitting answers with inconsistent results, is in accordance with other previous Swedish questionnaire studies (1, 3, 31) . The method to ask for HT use in several ways and to exclude the women who answered inconsistently is a way to strengthen the study by increasing its internal validity.
Furthermore, we made a test-retest analysis of the questionnaire before start of the study, and found that for almost all attitude questions women ticked the same box or just moved one step in any direction the second time. This suggests that women did not just answer "at random". Furthermore, the response profiles to some of our questions were almost identical in 1999 and 2003 (Table 2 , cf questions "MT leads to increased freedom…." and "It is a relief no longer to have to think about contraception"), which is also a strength.
Sometimes very small and clinically insignificant, but statistically significant, differences were found between some of the statements when comparing the 1999 and 2003 cohorts. This is probably a result of a very high statistical power, which is expected in a large population-based study and makes it important to interpret the result from a clinical point of view. To get a deeper understanding of women's attitudes towards and knowledge about the menopausal transition a qualitative approach could be useful as a complement to quantitative studies.
A weakness in our study is the fact that it mainly involved Swedish born women. The studied community has a rather low number of immigrants in general, and especially among women who have reached postmenopausal age. Moreover the dropout rate due to linguistic problems was probably higher among women born outside Sweden than among Swedish women. Therefore our conclusions are mainly based on Swedish-born women.
There are several studies showing that attitudes to the menopausal transition differ between cultures (32, 33) . Women from Asian cultures often have a more positive attitude towards aging, and women's status is often higher after menopause than before (33) , something that is less evident in most western cultures. In a previous study from our area, we found that postmenopausal immigrants from South-America had a very similar prevalence of menopausal symptoms but a much lower rate of HT-use than that of Swedish women (34), possibly due to lower access to the health care system. Use of hormone therapy had decreased substantially between 1999 and 2003, which is similar to findings in other populations from the same period (4, (21) (22) (23) (24) (25) . Recent data from Sweden showed that women's as well as physicians' risk perception of side effects from HT were dramatically changed over the same time period (25, 35) . It is probably dependent on updated information to both women and health care providers on risks and benefits of long-term use of HT.
The menopausal status may affect women's attitudes. Several longitudinal studies have shown that during the menopausal transition, women's attitudes change from a pessimistic view to a more neutral or optimistic one (15) (16) (17) . In a cross-sectional Swedish study postmenopausal women described the menopausal transition as easier than expected compared to the attitudes put forward by premenopausal women (31) . In line with these previous studies we found more optimistic views after menopause, e.g more post-than perimenopausal women agreed that menopause leads to increased freedom and relief from Women currently using HT seemed to have a more "biological" view on the menopausal transition than non-users. Significantly more users than non-users of HT thought that the menopausal transition is characterized by hormone deficiency, and were positive to HT use, although most of them looked at menopause as a natural process and as a sign of aging. Of course attitudes have once affected women to start or abstain from HT, but probably their experience from use of HT has also affected their general opinions on such therapy. These attitudes, mainly those regarding HT use, were significantly different in the cohort responding after publication of, and extensive media discussions about, the WHIand HERS-studies (Table 2) The most difficult statement to either totally agree or disagree upon was the one about factors influencing psychological discomfort, which is in accordance with results from Lewin et al (20) . Apparently most women did not agree that psychological discomfort is dependent on external factors or hormonal/biological changes only, but is probably a result of both. No conflicts of interests. Table 1 The menopausal transition is a natural process The menopausal transition is characterized by hormone deficiency
The menopausal transition is a sign of ageing Women with significant climacteric symptoms should use hormone replacement therapy
The menopausal transition leads to increased freedom for the woman Since the menopausal transition is associated with decreasing hormone levels all women should use hormone replacement therapy
The male partner of a woman in the menopausal transition regards her as less attractive It is a relief to know that you may no longer become pregnant A woman feels less feminine after menopause It is a relief to no longer have to think about contraception Psychological discomfort during the menopausal transition is caused more by a changing life situation (for example children leaving home) than by hormonal changes 
